Owner Scorecard


← All companies ← DBRG Manual DBX → ← CRSP Biotechnology DNA →

DBVT, DBV Technologies S.A.

Biotechnology consumer brand UnprofitableNet current asset value

DBV Technologies is a late-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin.

Our therapeutic approach is based on epicutaneous immunotherapy, or EPIT, our proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch).

Viaskin patch targets antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph nodes in order to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body.

Latest annual: FY2025 10-K
DBVT · DBV Technologies S.A.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$6M
+35.8% YoY · −13% 5-yr CAGR
Vital signs · TTM
Cash & investments $175M
Cash burn · annual $169M
Runway 1.0 yrs

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation
Unprofitable. No meaningful revenue yet; the record is the cash on hand against the burn. Net current asset value. Current assets alone exceed every liability combined, and the surplus is most of the balance sheet: the shape Graham called a net-net.
What moves the needle
Operating margin has run around −1728% through the cycle, the operating line deeply negative — so the lever is the path to a margin at all: revenue growth against the cost curve and the cash runway, not the level of a margin that isn't there yet. Stock-based pay runs about 96% of sales, a real and recurring claim on owners that the GAAP margin understates. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?
Return on capital has rarely cleared the cost of capital (median −1206%, above 15% in 0 of 3 years). Owner earnings, the cash-based check, have been thin too. This is price-taker territory, where the balance sheet and the cycle matter more than any multiple; the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

Most recent quarterly filing 10-Q filed Jul 16, 2026 Source at SEC EDGAR →

Revenue down 53.3% year over year

figures computed from the filing's XBRL

The record, 2019–2025

realized figures from each filing · older years to the left
2019’192020’202021’212022’222023’232024’242025’25TTMTTMJun 2026
Income statement
$15M$11M$6M$5M$16M$4M$6M$5MRevenueRevenue
334%311%535%502%188%692%582%869%SG&A / revenueSG&A/rev
783%901%n/mn/m383%n/mn/mn/mR&D / revenueR&D/rev
($171M)($159M)($99M)($97M)($76M)($117M)($147M)($178M)Operating incomeOp. inc.
n/mn/mn/mn/m−486.0%n/mn/mn/mOperating marginOp. mgn
($172M)($160M)($98M)$96M$73M($114M)($147M)($176M)Net incomeNet inc.
Cash flow & returns
($148M)($166M)($108M)($56M)($80M)($104M)($121M)($169M)Operating cash flowOp. cash
$4M$4M$3M$4M$3M$3M$3MDepreciationDeprec.
$6M($9M)($18M)($160M)($162M)$2M$17M($5M)Working capital & otherWC & other
$6M$3M$910K$754K$677K$2M$532K$1MCapexCapex
37.9%24.7%15.9%15.6%4.3%56.3%9.4%26.4%Capex / revenueCapex/rev
($154M)($168M)($109M)($56M)($80M)($107M)($122M)($171M)Owner earningsOwner earn.
n/mn/mn/mn/m−510.7%n/mn/mn/mOwner earnings marginOE mgn
($154M)($168M)($109M)($56M)($80M)($107M)($122M)($171M)Free cash flowFCF
n/mn/mn/mn/m−510.7%n/mn/mn/mFree cash flow marginFCF mgn
-9727%-1206%-347%ROICROIC
-89%-78%-99%50%52%-416%-87%-110%Return on equityROE
−89%−78%−99%50%52%−416%−87%−110%Retained to equityRetained/eq
Balance sheet
$193M$196M$77M$209M$141M$32M$194M$175MCash & investmentsCash+inv
$2M$0$0$0$0ReceivablesReceiv.
$2M$0$0InventoryInvent.
$24M$20M$11M$14M$23M$22M$41M$12MAccounts payablePayables
($22M)($18M)($11M)($14M)($23M)($12M)Operating working capitalOper. WC
$205M$207M$114M$223M$159M$44M$213M$202MCurrent assetsCur. assets
$54M$53M$31M$30M$37M$31M$58M$54MCurrent liabilitiesCur. liab.
3.8×3.9×3.6×7.6×4.3×1.4×3.7×3.7×Current ratioCurr. ratio
$272M$272M$147M$247M$183M$66M$234M$223MTotal assetsAssets
$1M$1M$510K$1MTotal debtDebt
($192M)($195M)($77M)($174M)Net debt / (cash)Net debt
$193M$205M$99M$194M$140M$27M$169M$160MShareholders’ equityEquity
117.2%−10.0%54.7%103.8%38.3%111.3%95.6%168.5%Stock comp / revenueSBC/rev
Per share
55.5M54.1M54.9M77.4M95.1M97.0M140M425MShares out (diluted)Shares
$0.26$0.21$0.10$0.06$0.17$0.04$0.04$0.01Revenue / shareRev/sh
$-3.10$-2.95$-1.78$1.24$0.76$-1.17$-1.05$-0.41EPS (diluted)EPS
$-2.77$-3.11$-1.99$-0.73$-0.84$-1.10$-0.87$-0.40Owner earnings / shareOE/sh
$-2.77$-3.11$-1.99$-0.73$-0.84$-1.10$-0.87$-0.40Free cash flow / shareFCF/sh
$0.10$0.05$0.02$0.01$0.01$0.02$0.00$0.00Cap. spending / shareCapex/sh
$3.48$3.80$1.81$2.51$1.47$0.28$1.21$0.38Book value / shareBVPS

Share counts before 2020 are restated ×1.5 for a stock split, so per-share figures sit on one basis.

The diluted share count moved ×1.41 into 2022 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.

The diluted share count moved ×1.44 into 2025 — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.

The diluted share count moved ×3.04 into TTM — shares issued, not a split the totals corroborate — and the per-share figures carry the counts as filed.

Per-share growththe realized rate an owner's share compounded
6-yr5-yr
Revenue / share−26.9%/yr−28.0%/yr
Capital spending / share−42.0%/yr−40.6%/yr
Book value / share−16.2%/yr−20.5%/yr

The record, charted

FY2019–2025

Each measure over its full record; the current point and the worst year marked. Share counts on the current split basis.

Share count
140Mpeak FY2025
ROIC
−347%low FY2019

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

($122M)owner earningsvs.($147M)net incomelow FY2020

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned a $147M loss into ($122M) of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

FY2025FY2024FY2023FY2022FY2021
Reported net income($147M)($114M)$73M$96M($98M)
Depreciation & amortizationnon-cash charge added back+$3M+$3M+$4M+$3M+$4M
Stock-based compensationreal costnon-cash, but a real cost+$5M+$5M+$6M+$5M+$3M
Working capital & othertiming of cash in and out, other non-cash items+$17M+$2M−$162M−$160M−$18M
Cash from operations($121M)($104M)($80M)($56M)($108M)
Capital expenditurecash put back in to keep running and to grow−$532K−$2M−$677K−$754K−$910K
Owner earnings($122M)($107M)($80M)($56M)($109M)
Owner-earnings marginowner earnings ÷ revenue-2160%-2573%-511%-1165%-1912%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $5M), owner earnings is nearer ($127M).

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • No meaningful interest burden
    Little or no interest expense reported
    What this means

    Little or no interest expense reported, the business isn't leaning on lenders to operate.

  • Net cash
    Cash $194M − debt $1M
    What this means

    Cash and short-term investments exceed every dollar of debt by $193M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

Is it a good business?

  • Not meaningful here
    Invested capital ($24M) = debt $1M + equity $169M − cash
    Industry peers: median -45%
    What this means

    Invested capital is near zero or negative, usually years of buybacks pulling equity down. ROIC explodes or flips sign and stops meaning anything. Judge this one on Owner Earnings instead.

  • Consumes cash through the cycle
    7-yr median margin, range -2573%–-511%; latest ($122M) = operating cash ($121M) − maintenance capex $532K
    Industry peers: median -1295%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -2160% of revenue this year, a -1493% median across 7 years. Treating stock comp as the real expense it is (less $5M of SBC) leaves ($127M).

  • Loss, and burning cash
    Net income ($147M) · cash from operations ($121M)
    What this means

    The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did not.

How is the cash used?

  • Not enough data
    What this means

    The filing data didn't include the inputs for this check.

  • Investing or harvesting? 0.18×
    Harvesting
    Capex $532K ÷ depreciation $3M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 2 of 5 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Miss
    Revenue ≥ $2B · $6M
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Pass
    Current ratio ≥ 2× · 3.67×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Pass
    Debt ≤ working capital · $1M vs $155M WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Earnings stability Miss
    A profit every year (7-yr record) · 5 loss years
    What this means

    Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.

  • Dividend record Miss
    Uninterrupted dividends · none paid
    What this means

    An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.

  • Earnings growth
    Earnings +33% over the record ·
    What this means

    Earnings were negative early in the record, a growth rate isn't meaningful.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-0.21/share (latest year $-0.50), the averaged base the calculator's gate runs on, and book value is $0.57/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2019–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 2 of 7
    What this means

    Lost money in 5 year(s), look at what happened there before trusting the average.

  • Return on capital ≥ 15% 0 of 3 yrs
    What this means

    A moat shows up as a high return on invested capital that holds year after year, not one good vintage.

  • Operating margin −1433% → −1968% (3-yr avg ends)

    In the filing’s words The filing attributes gains to higher prices, but the margin in the record has not followed — the claim outruns the result here.

    What this means

    Through the cycle the operating margin slipped — about −1433% early to −1968% lately, median −1728% — competition or costs are biting in.

  • Reinvestment, incremental ROIC returns capital
    What this means

    The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.

  • Worst year 2024 · −2808.7% op. margin
    What this means

    Operations went underwater in 2024, understand why before trusting the good years.

Does AI threaten the moat?

Low contestability

The moat is physical, regulated or balance-sheet-funded, the kind AI cuts costs within but does not contest.

AI is unlikely to contest a moat that is physical, regulated or balance-sheet-funded; here it reads more as a cost tool than a threat.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$202M
  • Cash & short-term investments$175M
  • Other current assets$27M
Current liabilities$54M
  • Debt due within a year$810K
  • Accounts payable$12M
  • Other current liabilities$42M
Current ratio3.72×all current assets ÷ what's due · Graham looked for 2×
Quick ratio3.72×stricter: inventory excluded
Cash ratio3.22×strictest: cash alone against what's due
Working capital$148Mthe cushion left after near-term bills
Debt due this year vs. cash$810K due · $175M cash covered by cash on hand, no refinancing forced · both figures from the Jun 30, 2026 balance sheet
Cash runway1.0 yrsthe business is consuming cash; this is how long the cash on hand lasts at that rate
Revenue, latest quarter vs. a year ago−53.3%the freshest read on whether the business is still growing
Current ratio, recent quarters2.2× → 3.7×
Deeper floors
Tangible book value$160Mequity stripped of goodwill & intangibles
Net current asset value$139MGraham's net-net: current assets less all liabilities
Debt incl. operating leases$9M$8M of it operating leases

From the company's latest filing.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2023Daniel Tasse$2.4M$978k($80M)
2024Daniel Tasse$1.6M−$506k($107M)
2025Daniel Tasse$3.4M$7.7M($122M)

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Stock-based compensation$5M

    The slice of the business handed to employees in shares this year, 96% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

What an owner would ask, FY2025

read the 10-K →
  • Which reported numbers are a judgment call?
    Management names Stock compensation as critical estimates

    each rests partly on management's judgment; the filing's note sets out the assumptionsverify →

The questions the record and the charts do not answer on their own; each carries the figure and the place to look.

Peers, Biotechnology

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

CompanyRevenueGross marginOp. marginROICOwner earn. margin
ACOGAlpha Cognition Inc.$10M-221.7%-200%
TSHATaysha Gene Therapies Inc.$10M-1114.1%-970%
SLDBSolid Biosciences Inc.$8M-2214.1%-152%-1945%
OVIDOvid Therapeutics Inc.$7M-2170.9%-64%-2143%
DBVTDBV Technologies S.A.$6M-1727.6%-1206%-1493%
OCGNOcugen Inc.$4M-1425.7%-1295%
CGONCG Oncology Inc.$4M-10067.3%-21%-3279%
CRSPCRISPR Therapeutics AG$4M-1284.9%-27%-715%
Group median-1576.7%-64%-1394%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

DBV Technologies S.A. is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.

$
The assumptions

Revenue, delivered−9%/yr’20→’25

Enter a price to run it.

Owner earnings it must reach
Margin the price demands
Owner-earnings margin today−3388%

Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.

Cite: Owner Scorecard, "DBV Technologies S.A. (DBVT), the owner's record," https://ownerscorecard.com/c/DBVT, data as of 2026-07-09.

Manual order: ← DBRG its page in the Manual DBX →

Industry order: ← CRSP the Biotechnology chapter DNA →